Home › Mild Cognitive Impairment › Minnesota
Mild Cognitive Impairment clinical trials in Minnesota
6 studies for Mild Cognitive Impairment are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Struthers Parkinson's Center, Golden Valley
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
- University of Minnesota Health, Minneapolis
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04916210Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Essentia Health, Duluth
- Mayo Clinic, Rochester
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- HealthPartners Neuroscience Center, Saint Paul
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 29, 2026 · NCT06897670Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
- Minneapolis VA Health Case System, Minneapolis
Recruiting
Ages 18 to 60 · All sexes · Updated Nov 12, 2025 · NCT06413173From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.